New Current Report Filed with the SEC Relating to Statement that Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review Should Not Be Relied Upon: 8-K – PharmaCyte Biotech, Inc. (0001157075) (Filer)

A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC) relating to a statement that certain of the company’s previously-issued financial statements or a related audit report or completed interim review should not be relied upon by investors or other interested parties. Details of the current report are:

8-K – PharmaCyte Biotech, Inc. (0001157075) (Filer)
Filed: 2015-12-31 AccNo: 0001019687-15-004674 Size: 31 KB

Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Filing Date: 2015-12-31T09:23:15-05:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: http://www.sec.gov/Archives/edgar/data/1157075/000101968715004674/0001019687-15-004674-index.htm